These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 3476825

  • 21. [Gingival hyperplasia due to diphenylhydantoin, cyclosporin A and nifedipine. A histopathological comparison].
    Silvestri E, Veraldi S, Piferi M, Sala F, Bencini L, Marini D.
    Minerva Stomatol; 1988 Mar; 37(3):189-92. PubMed ID: 3166093
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Incidence and indications for surgical management of phenytoin-induced gingival overgrowth in a cerebral palsy population.
    Jones JE, Weddell JA, McKown CG.
    J Oral Maxillofac Surg; 1988 May; 46(5):385-90. PubMed ID: 3163372
    [Abstract] [Full Text] [Related]

  • 24. The potential use of CO2-laser gingivectomy for phenytoin-induced gingival hyperplasia in mentally retarded patients.
    Roed-Petersen B.
    J Clin Periodontol; 1993 Nov; 20(10):729-31. PubMed ID: 8276983
    [Abstract] [Full Text] [Related]

  • 25. [Hyperplasia caused by diphenylhydantoin in patients with and without teeth (II)].
    Dreyer WP, Thomas CJ.
    Med Hyg (Geneve); 1982 Mar 10; 40(1461):932-4. PubMed ID: 6955585
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Current trends in periodontology. Hypertrophic-hyperplastic gingivopathy due to diphenylhydantoin].
    Weinstein R.
    Mondo Odontostomatol; 1986 Mar 10; 28(2):81-6. PubMed ID: 3462493
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The gingival hyperplasia resulting from diphenylhydantoin in children and adults.
    Matsumoto K, Nakagawa K, Kaneko Z.
    Int J Clin Pharmacol Biopharm; 1975 Oct 10; 12(3):369-71. PubMed ID: 1176242
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Levels of 5,5-diphenylhydantoin and its major metabolite in human serum, saliva, and hyperplastic gingiva.
    Conard GJ, Jeffay H, Boshes L, Steinberg AD.
    J Dent Res; 1974 Oct 10; 53(6):1323-9. PubMed ID: 4529919
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prevention and treatment of Dilantin-associated gingival enlargement.
    Pihlstrom BL.
    Compend Suppl; 1990 Mar 06; (14):S506-10. PubMed ID: 2097044
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.